Comment from Disability Rights Education and Defense Fund
AnonymousSupportAdvocacy
Summary: The Disability Rights Education and Defense Fund (DREDF) supports the petition to remove the Mifepristone REMS Program's in-person dispensing requirement. They argue that reinstating such a requirement would create illegal structural barriers to healthcare for people with disabilities, violating the FDCA and federal disability rights laws like the ADA and Section 504.
See attached comments from the Disability Rights Education and Defense Fund (DREDF) in Support of Citizen Petition FDA-2025-P-3287-0001.